From Name:
From Email:
To Name:
To Email:

Optional Message:

Setback for new stem cell treatment

from The New York Times

In an unexpected setback to efforts to harness a promising new type of stem cell to treat diseases, researchers reported that tissues made from those stem cells might be rejected by a patient's immune system — even though the tissues would be derived from the same patient. The research involved so-called induced pluripotent stem cells, or iPS cells, which can be made from skin cells and which appear to have the characteristics of embryonic stem cells. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063